prise de sang

BIOLOGICAL3 trials

Sponsors

Centre Hospitalier Universitaire Dijon

Conditions

Ischemic StrokeType 1 and 2 Diabetesdiabète de Type 1

Unknown Phase

Genetic Polymorphisms, Steatosis and Diabetes

CompletedNCT02045563

Centre Hospitalier Universitaire DijonType 1 and 2 Diabetes

Start: 2007-10-15End: 2015-03-25Updated: 2024-02-21

Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesteryl Ester Transfer Protein in Type-1 Diabetes Patients

CompletedNCT02816099

Centre Hospitalier Universitaire Dijondiabète de Type 1

Start: 2014-11-20End: 2022-11-14Updated: 2026-02-06

Functional Prognosis in Patients With Ischemic Stroke According to the Therapeutic Strategy Used

CompletedNCT02856074

Centre Hospitalier Universitaire DijonIschemic Stroke

Start: 2016-01-13End: 2020-06-01Updated: 2021-11-26

Related Papers

The Endogenous Inhibitor of CETP, apoC1, Remains Ineffective In Vivo after Correction of Hyperglycemia in People with Type 1 Diabetes

Metabolites2024-09-071 citations

HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control.

2022-08-126 citations